SLC19A3 and breast cancer: This suggests cell-specific susceptibility, similar to what reported in other diseases: THTR2 was shown downregulated in Sprague–Dawley rats with chronic kidney disease [24], upregulated in breast cancer [25], and unchanged in erythrocytes of diabetic subjects, in comparison with healthy controls [22].